Latham & Watkins represented Innocoll Biotherapeutics in the transaction.
Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, has announced the successful closing of a new US$125 million term loan provided by funds managed by Oaktree Capital Management, L.P.
Innocoll Biotherapeutics plc is a global specialty pharmaceutical company headquartered in Athlone, Ireland. Innocoll Biotherapeutics plc and its subsidiaries Innocoll Holdings Limited and Innocoll Pharmaceuticals Limited, are focused on the development and commercialization of pharmaceutical technologies to meet some of today’s most important healthcare challenges.
Oaktree is a leader among global investment managers specializing in alternative investments, with $166 billion in assets under management as of December 31, 2021. The firm emphasizes an opportunistic, value-oriented and risk-controlled approach to investments in credit, private equity, real assets and listed equities. The firm has over 1,000 employees and offices in 19 cities worldwide.
Latham & Watkins represented Innocoll Biotherapeutics with a transactional team led by California finance partners Haim Zaltzman (Picture) and Elizabeth Oh, with associates Hyunji Lee and Dong Whi (Tony) Noh. Advice has also been provided on corporate matters by California partner Ben Potter and Boston associate Erik Thompson; on intellectual property matters by California partners Judith Hasko and Jekkie Kim; on ERISA matters by California partner Julie Crisp; on regulatory matters by California counsel Betty Pang and Washington, D.C. associate Chad Jennings; on tax matters by California partner Katharine Moir and associate Alexander Farris; and on German legal matters by Frankfurt partner Torsten Volkholz and associate Anna-Maria Kuckerz.
Involved fees earner: Julie Crisp – Latham & Watkins; Alexander Farris – Latham & Watkins; Judith Hasko – Latham & Watkins; Chad Jennings – Latham & Watkins; Jekkie Kim – Latham & Watkins; Anna-Maria Kuckerz – Latham & Watkins; Hyunji Lee – Latham & Watkins; Katharine Moir – Latham & Watkins; Tony Noh – Latham & Watkins; Elizabeth Oh – Latham & Watkins; Betty Pang – Latham & Watkins; Benjamin Potter – Latham & Watkins; Erik Thompson – Latham & Watkins; Torsten Volkholz – Latham & Watkins; Haim Zaltzman – Latham & Watkins;
Law Firms: Latham & Watkins;
Clients: Innocoll Biotherapeutics;